Timothy Hohman has been awarded a Post Doctoral Fellowship in Translational Medicine and Therapeutics from the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation. The goal of the PhRMA Foundation Translational Medicine and Therapeutics Program is to promote the development and use of experimental and computational methods in an integrative approach towards clinical needs in diagnosis, treatment and prevention. This award provides $60,000 per year in stipend support for up to two years. Awesome job, Tim!
The PhRMA Foundation
Mary Ellen Koran and fellow MSTP student Young Lee were selected to speak at the 2012-2013 Felxner Dean Lecture Series, to be held Friday, March 1, 2013 at 12pm in 208 Light Hall. It is a great honor to give one of the Flexnor Dean Annual Student Lectures, and her presentation on “Genetic Engineering: From Therapy in the Clinic to Doping on the Field” was selected from among many proposals. Congratulations, Mary Ellen!
Timothy Hohman was awarded a Human Amyloid Imaging (HAI) 2013 Travel Scholarship for his abstract submission entitled, “Epistasis and amyloid burden in the Alzheimer’s Disease Neuroimaging Initiative.” The award includes $1000 for travel to the conference, and Dr. Hohman will be formally recognized during the conference. the HAI Conference will be held in Miami, FL on January 16-18, 2013.
Jennifer Pryweller has been awarded financial support from the Vanderbilt Institute for Clinical and Translational Research (VICTR) for her dissertation project, “A neural basis for atypical auditory processing in Williams syndrome.” This grant will support the recruitment and MRI scans for neurotypical control subjects whose brain connectivity will be compared that of individuals with Williams syndrome, whose data have already been collected. The Vanderbilt Institute of Imaging Science has also awarded matching funds to support this project.
Jennifer has also received two travel grants–one from the Vanderbilt Graduate School and one from the Vanderbilt Kennedy Center–to support her attending the Society for Neuroscience Annual Meeting to be held October 13-17, 2012 in New Orleans, LA. Jennifer will be presenting her work entitled, “A neural basis of atypical auditory processing in Williams syndrome.”
Jennifer Vega has received three travel grants–from the Neuroscience Clinical Scholars Program, Vanderbilt Graduate School and the Human Genetics Training Grant–to support her attending the American Society for Human Genetics Annual Meeting to be held November 6-10, 2012 in San Francisco, CA. Jennifer will be presenting her work entitled, “Replication and generalization of genetic risk factors for depression and anxiety in a population based cohort with African, European and Mexican ancestries.”
Mary Ellen Koran has received two travel grants–one from the Vanderbilt Graduate School and one from the Vanderbilt Kennedy Center–to support her attending the Society for Neuroscience Annual Meeting to be held October 13-17, 2012 in New Orleans, LA. Mary Ellen will be presenting her work entitled, “Genetic interactions in focal adhesion and extracellular matrix pathways are associated with increase in ventricle size over time in the Alzheimer””s Disease Neuroimaging Initiative cohort.”
The Thornton-Wells Lab has been awarded pilot funding from the Vanderbilt Brain Institute (VBI) for the following project:
“MRI Endophenotypes of Chemotherapy-Induced Cognitive Impairment (CICI)”
PI: Tricia Thornton-Wells, Ph.D.
Co-Investigators: Sheila Ridner, Ph.D., Mia Levy, M.D., Paul Newhouse, M.D., Chad Quarles, Ph.D., James Jackson, Ph.D., Hakmook Kang, Ph.D.
This study will investigate genetic susceptibility factors, premorbid cognitive indicators and early post-chemotherapy neuroimaging measures that could be used to predict risk for the development of chemotherapy-induced cognitive impairment. Results could inform and enable early identification of at-risk patients for whom preemptive, cognitive rehabilitation and pharmacological therapies would be most efficacious.
This grant will support the recruitment and enrollment of 10 subjects, including serum cytokine measurements, DNA sample collection, APOE genotyping and MRI scans.
The Thornton-Wells Lab has been awarded funding from the Vanderbilt Institute of Clinical and Translational Research (VICTR) for the following project:
“MRI Biomarkers and Genetic Risk Factors for Alzheimer Disease”
PI: Tricia Thornton-Wells, Ph.D.
Co-Investigators: Brandon Ally, Ph.D., William Petrie, M.D., Brian Welch, Ph.D., Daniel Claassen, M.D., Christopher Tolleson, M.D.
This study will investigate non-invasive MRI scan sequences that could serve as effective screening tools for early Alzheimer’s-related pathology, which could translate into very early identification of persons at high-risk of developing the disease. MRI biomarkers will be evaluated for diagnostic utility in persons with amnestic mild cognitive impairment versus cognitively normal controls. Peripheral measures of amyloid-beta proteins from cerebrospinal fluid will be correlated with MRI biomarkers aimed at detecting the presence of amyloid-beta plaques in the brain.
This grant will support the recruitment and enrollment of 40 subjects, including MRI scans, DNA sample collection and CSF sample collection.
Jennifer Vega has been awarded the 2012 Clinical Neuroscience Scholars Fellowship sponsored by the JB Marshall Foundation, the Dan Marino Foundation and the Vanderbilt Brain Institute.
Jenna is a Ph.D. student in the Neuroscience Graduate Program, and through the Clinical Neuroscience Scholars Program, Jenna will receive additional training and mentorship from Dr. William Petrie, who a Professor of Clinical Psychiatry and the Director of the Geriatric Psychiatry Outpatient Program at Vanderbilt.